New findings show that these diabetes and weight-loss drugs may actually change the way our bodies process alcohol.
GLP-1 drugs like semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, were originally intended to treat diabetes — and didn’t become blockbuster prescriptions until doctors realized that they were also potent weight loss aids that... [2415 chars]